Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Aarushi Audhut, Sofie Deschoemaeker, Lize Allonsius, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4037-4037
Open Access | Times Cited: 20

Showing 20 citing articles:

Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 43
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189281-189281
Closed Access | Times Cited: 2
Adoptive T cell therapy for ovarian cancer
Sarah B. Gitto, Chibuike Ihewulezi, Daniel J. Powell
Gynecologic Oncology (2024) Vol. 186, pp. 77-84
Closed Access | Times Cited: 8
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Regulatory effects of IRF4 on immune cells in the tumor microenvironment
Jing Lu, Taotao Liang, Ping Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Immunotherapeutic Approaches in Ovarian Cancer
Hyunho Yoon, Ayoung Kim, Hoon Jang
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1233-1249
Open Access | Times Cited: 12
Limitations and potential of immunotherapy in ovarian cancer
Sandeep Kumar, Sayanti Acharya, Mahalakshmi Karthikeyan, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Nanotechnology for boosting ovarian cancer immunotherapy
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Targeting the immune microenvironment in ovarian cancer therapy—mission impossible?
Félix Blanc‐Durand, Patricia Pautier, J. Michels, et al.
ESMO Open (2024) Vol. 9, Iss. 3, pp. 102936-102936
Open Access | Times Cited: 3
Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development
Razvan Zdrehus, Cristian Delcea, Lucian Mocan
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 410-410
Open Access | Times Cited: 2
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
STATs signaling pathways in dendritic cells: As potential therapeutic targets?
Sepideh Sohrabi, Javad Masoumi, Bahar Naseri, et al.
International Reviews of Immunology (2023) Vol. 43, Iss. 3, pp. 138-159
Closed Access | Times Cited: 5
Role of Biofunctionalized Nanoparticles in the Digestive Cancer Vaccine Development
Razvan Zdrehus, Cristian Delcea, Lucian Mocan
(2024)
Open Access | Times Cited: 1
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
Mark DeBenedette, Alicia Gamble, Marcus S. Norris, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data
Zhou Zhu, Hang Jin, Jian Xu
Annals of Translational Medicine (2023) Vol. 11, Iss. 1, pp. 20-20
Open Access | Times Cited: 2
Systemic treatment of ovarian cancer
Mária Hanišová, Munachiso Ndukwe
Onkologie (2024) Vol. 18, Iss. 1, pp. 25-31
Closed Access
Insights into the Microbial Composition of Intratumoral, Reproductive Tract, and Gut Microbiota in Ovarian Cancer Patients
Qian Zhou, Qingren Meng
Advances in experimental medicine and biology (2024), pp. 107-118
Closed Access
Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital
Cen Jiang, Yiyi Lu, Hua Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Development of cell-based vaccines in cancer treatment
Mengfei Chen
Highlights in Science Engineering and Technology (2023) Vol. 36, pp. 1342-1346
Open Access
Page 1

Scroll to top